Engineering bacteria as interactive cancer therapies

CR Gurbatri, N Arpaia, T Danino - Science, 2022 - science.org
With increasing evidence that microbes colonize tumors, synthetic biology tools are being
leveraged to repurpose bacteria as tumor-specific delivery systems. These engineered …

Pancreatic cancer: a review of current treatment and novel therapies

HM Kolbeinsson, S Chandana, GP Wright… - Journal of Investigative …, 2023 - Taylor & Francis
Pancreatic cancer is one of the leading causes for cancer-related deaths in the United
States. Majority of patients present with unresectable or metastatic disease. For those that …

[HTML][HTML] Genetically engineered bacterium: Principles, practices, and prospects

Y Liu, J Feng, H Pan, X Zhang, Y Zhang - Frontiers in Microbiology, 2022 - frontiersin.org
Advances in synthetic biology and the clinical application of bacteriotherapy enable the use
of genetically engineered bacteria (GEB) to combat various diseases. GEB act as a small …

[HTML][HTML] The role of metabolic plasticity of tumor-associated macrophages in shaping the tumor microenvironment immunity

MN Hasan, O Capuk, SM Patel, D Sun - Cancers, 2022 - mdpi.com
Simple Summary Tumor associated macrophages (TAMs) support disease progression by
providing tumor cells cytokines and chemokines necessary for malignant growth and …

[HTML][HTML] Listeria monocytogenes: a promising vector for tumor immunotherapy

YD Ding, LZ Shu, RS He, KY Chen, YJ Deng… - Frontiers in …, 2023 - frontiersin.org
Cancer receives enduring international attention due to its extremely high morbidity and
mortality. Immunotherapy, which is generally expected to overcome the limits of traditional …

Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context

Y Liu, L Niu, N Li, Y Wang, M Liu, X Su, X Bao… - Advanced …, 2023 - Wiley Online Library
Targeted therapy and immunotherapy have brought hopes for precision cancer treatment.
However, complex physiological barriers and tumor immunosuppression result in poor …

Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines

M Oladejo, W Paulishak, L Wood - Seminars in Cancer Biology, 2023 - Elsevier
Cancer vaccines and immune checkpoint inhibitors (ICIs) function at different stages of the
cancer immune cycle due to their distinct mechanisms of action. Therapeutic cancer …

[HTML][HTML] Current status and future directions of bacteria-based immunotherapy

Q Tang, X Peng, B Xu, X Zhou, J Chen… - Frontiers in …, 2022 - frontiersin.org
With the in-depth understanding of the anti-cancer immunity, immunotherapy has become a
promising cancer treatment after surgery, radiotherapy, and chemotherapy. As natural …

Genetically engineered bacteria: a new frontier in targeted drug delivery

S Fooladi, N Rabiee, S Iravani - Journal of Materials Chemistry B, 2023 - pubs.rsc.org
Genetically engineered bacteria (GEB) have shown significant promises to revolutionize
modern medicine. These engineered bacteria with unique properties such as enhanced …

[HTML][HTML] Advances in immunotherapeutics in pancreatic ductal adenocarcinoma

T Chouari, FS La Costa, N Merali, MD Jessel… - Cancers, 2023 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is the most common type of
pancreatic cancer, responsible for the majority of cases and ranking seventh as a leading …